Can Radiotracers Predict Response to PD-L1 Inhibitors in Early NSCLC?
Although immunotherapy advances have improved cancer treatments, there remains a need for reliable biomarkers.
Read More
Meeting Coverage
Birdshot Chorioretinopathy Shows Fractal Changes in the Retinal Vascular Layers
Fractal dimensions represent a promising biomarker for assessing retinal vascular damage.
Read More
Treating Patients of Color With Psoriasis Presents Many Challenges
Dermatologists must be knowledgeable about differences among people of color with psoriasis and to tailor their approach to diagnosis and treatment accordingly.
Read More
Q&A: Sharing Knowledge Fosters a Better Understanding of MS
Progression independent of relapse activity explains why certain patients with MS continue to worsen clinically without MRI evidence of new lesions.
Read More
Q&A: Using Effective Treatments Earlier for NSCLC
“With lung cancer we’re treating more patients effectively today and even curing them because we’re using our most effective therapies earlier.”
Read More
Q&A: Availability of Multiple Options for NSCLC is “Very Exciting”
Selecting a treatment for operable non-small cell lung cancer from the many options available involves consideration of tumor stage and biomarkers.
Read More
Key Presentations Focused on MS
Check out the key presentations from AAN Fall Clinical on MS. And follow along for more from AAN.
Read More
Addressing Educational & Research Gaps in Treating Psoriasis in Patients With All Skin Types
Educational and research gaps in treating plaque psoriasis in patients with skin of color can lead to delays in diagnosis and treatment.
Read More
Evaluating Efficacy of 8 mg Intravitreal Aflibercept After 48 Weeks for DME Based on Baseline Demographics
The following is a summary of “Intravitreal Aflibercept 8 mg for DME: Week 48 Efficacy Outcomes by...
Read More
AI Risk Scoring Model for Referable DR Prediction
The following is a summary of “A Multimodal AI Risk Scoring Model to Predict the Development of...
Read More
Subgroup Analyses of Aflibercept 8-mg Intravitreal Injection for nAMD Patients: Phase 3 PULSAR Trial
The following is a summary of “Intravitreal Aflibercept 8-mg Injection in Patients With nAMD:...
Read More
Explore, Connect, & Learn at the AAO 2023 Expo
Explore, connect, learn, relax and more at the AAO 2023 Expo. Follow PW for conference updates.
Read More
AAO Announces The Orbital 2023: Gold Rush Fundraising Event
AAO Announces The Orbital 2023: Gold Rush Fundraising Event, formerly the Orbital Gala.
Read More
Virtual Conference
AAO 2023 is offering a virtual version of their conference. Follow PW for conference highlights.
Read More
Analysis of Follow-up Traits in an Extensive Diabetes Teleretinal Screening Program
The following is a summary of “Follow-Up Characteristics in a Large Diabetic Teleretinal Screening...
Read More
Highlights From ASRS – Retinal Vascular Disease
A curated ebook on ASRS 2023 with a focus on retinal vascular disease, featuring recent studies, findings, and opinions from thought leaders.
Read More
Patients With Retinal Vascular Disease More Prone to Dementia
People with retinal vascular disease, especially central retinal vein occlusion (RVO), are more likely to develop dementia.
Read More
What Do You Remember From AAN?
What do you remember from AAN? Test your knowledge now!
Read More
Agenda at a Glance, AAN
Take a look at the schedule for AAN Fall Conference. And follow along at PW for conference coverage.
Read More
Fun Facts & FAQs
Take a look at some of the fun facts about AAN Fall Conference. And follow PW for conference coverage.
Read More